338 related articles for article (PubMed ID: 33402729)
1. Roles of miRNA dysregulation in the pathogenesis of multiple myeloma.
Chen D; Yang X; Liu M; Zhang Z; Xing E
Cancer Gene Ther; 2021 Dec; 28(12):1256-1268. PubMed ID: 33402729
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA: important player in the pathobiology of multiple myeloma.
Bi C; Chng WJ
Biomed Res Int; 2014; 2014():521586. PubMed ID: 24991558
[TBL] [Abstract][Full Text] [Related]
5. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma.
Allegra A; Ettari R; Innao V; Bitto A
Cells; 2021 Feb; 10(2):. PubMed ID: 33672466
[TBL] [Abstract][Full Text] [Related]
7. The potential role of miRNAs in multiple myeloma therapy.
Caracciolo D; Montesano M; Altomare E; Scionti F; Di Martino MT; Tagliaferri P; Tassone P
Expert Rev Hematol; 2018 Oct; 11(10):793-803. PubMed ID: 30148649
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches.
Rossi M; Amodio N; Di Martino MT; Tagliaferri P; Tassone P; Cho WC
Curr Pharm Biotechnol; 2014; 15(5):459-67. PubMed ID: 24846067
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in the pathobiology of multiple myeloma.
Lionetti M; Agnelli L; Lombardi L; Tassone P; Neri A
Curr Cancer Drug Targets; 2012 Sep; 12(7):823-37. PubMed ID: 22671930
[TBL] [Abstract][Full Text] [Related]
10. miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
Tavakoli Pirzaman A; Ebrahimi P; Hasanpour AH; Shakeri M; Babajani B; Pourali Ganji Z; Babaei H; Rahmati A; Hosseinzadeh R; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231202391. PubMed ID: 37728167
[TBL] [Abstract][Full Text] [Related]
11. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
12. Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients.
Ren Y; Li X; Wang W; He W; Wang J; Wang Y
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):415-423. PubMed ID: 28601493
[TBL] [Abstract][Full Text] [Related]
13. Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment.
Tang W; Xu J; Xu C
Cancer Lett; 2023 Mar; 556():216081. PubMed ID: 36739065
[TBL] [Abstract][Full Text] [Related]
14. Aberrant microRNA expression in multiple myeloma.
Dimopoulos K; Gimsing P; Grønbæk K
Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment.
Botta C; Cuce M; Caracciolo D; Fiorillo L; Tagliaferri P; Tassone P
Curr Cancer Drug Targets; 2017; 17(9):819-838. PubMed ID: 28359248
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation of microRNA genes in multiple myeloma.
Wong KY; Huang X; Chim CS
Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance.
Puła A; Robak P; Robak T
Curr Med Chem; 2021 Oct; 28(33):6753-6772. PubMed ID: 33949926
[TBL] [Abstract][Full Text] [Related]
20. Promises and challenges of MicroRNA-based treatment of multiple myeloma.
Tagliaferri P; Rossi M; Di Martino MT; Amodio N; Leone E; Gulla A; Neri A; Tassone P
Curr Cancer Drug Targets; 2012 Sep; 12(7):838-46. PubMed ID: 22671926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
